How Stem Cells for Diabetes May Improve Quality of Life?

Diabetes Beyond Blood Sugar 

Living with diabetes means living with constant blood sugar monitoring, dietary restriction and long-term health complications. In recent times, regenerative medicine is opening up new therapeutic avenues for potential support to pancreatic repair and boost metabolic health. Globally, diabetes cases reported from 200 million in 1990 to 830 million in 2022 [1]. In India, 89.83 million cases were registered in 2024, with an estimate to rise to 183 million in 2050 [2]. 

Stem Cells for Diabetes management intend to regenerate insulin-producing pancreatic beta cells, repair complications, and reverse insulin resistance. 

Ask The Expert

Understanding the Science Behind Stem Cells for Diabetes

Stem cell therapy for diabetes is a regenerative approach that uses mesenchymal stem cells (MSCs) for the regeneration of pancreatic beta-producing cells. Meta-analysis conducted in 2025 based on 34 randomized controlled trials inferred a 2.79 times improvement in glycemic control in comparison to the placebo [3].   

Researchers Drive MSCs for Diabetes from Different Sources, Including:

• Umbilical cord tissue of blood
• Adipose (fat) tissue
• Placenta
• Bone marrow

Stem cells for diabetes are widely explored to combat co-morbid factors like diabetic foot ulcer (DFU), and diabetic peripheral neuropathy (DPN), along with beta cell regeneration. 

Why Conventional Therapy for Diabetes Management Falls Short?

Common Diabetes Management Includes:

• Medication (Metformin, SGLT-2 inhibitor, GLP-1 agent)
• Blood Glucose Monitoring & Insulin Therapy
• Dietary intervention & Weight management
• Physical exercise (Brisk walking, strength training)

These Conventional Therapies Address Symptom Management. However, They Do Not Address the Root Cause. The Primary Issue Includes:

• Conventional treatment does not regenerate or repair the exhausted pancreatic beta cells
• It cannot reverse insulin resistance, repair microvascular damage and address long-term complications
• A long-term diabetes patient develops other conditions like retinopathy, neuropathy, nephropathy, and cardiovascular disease
• Medication dosage or insulin concentration keeps fluctuating based on your blood sugar level ups and downs, yet nothing can stop the related complications 

How Stem Cell Therapy for Diabetes Works?

Diabetes Stem Cell Treatment makes changes intrinsically. The underlying mechanism includes:

• MSCs release growth factors and cytokines that regenerate and protect insulin-producing pancreatic cells.
• They restore cellular and molecular function that regulates insulin signalling, such as IRS-1/AKT, the GLUT4 pathway.
• Stem cells for diabetes combat chronic inflammation by releasing anti-inflammatory molecules (IL-10, PGE2, TGF-β). They decrease pro-inflammatory cytokine effect (TNF-α, IL-1β, IL-17). 
• MSCs regulate the conversion of M1 to M2 macrophages and improve liver glucose metabolism.

*MSCs undertake systemic action to combat metabolic disorder, rather than just symptom management

What is the Underlying Mechanism?

Stem Cells for Diabetes Target the Root Dysfunction. The Mechanism of Action Includes:

β-Cell Regeneration

• MSCs release growth factors- VEGF, IGF-1, TGF-β, HGF
• Stimulates regeneration and repair of β-cells
• Reduces free radical effect (combats oxidative stress)
• Suppresses cell death triggered by the inflammatory pathway
• In Diabetes Type 1, the introduction of stem cells regulates immune pathways, modulates the misdirected β-cells’ autoimmune response

Reverse Insulin Resistance

• Increases the expression of GLUT4 in liver muscle
• Restores IRS-1/AKT signalling pathway
• Promote communication with the target tissue
• Suppresses the NLRP2 inflammasome (inflammatory trigger) that blocks insulin 
• Signalling improves insulin sensitivity

Reset Systemic Anti-Inflammation

• Low-grade inflammation is a primary driver of Type 1 and Type 2 diabetes
• Converts pro-inflammatory M1 macrophages to anti-inflammatory M2 macrophages
• Boost the function of T-regulatory cells
• Sustain immune balance, shift systemic profile of cytokine from destructive to protective

Case Studies (2020-2026): Stem Cells for Diabetes

1. Nanjing Drum Tower Hospital, China

• In 2021, Dr. Zhu used allogenic umbilical cord (UC) MSCs among T1DM
• Repeated stem cell transplantation improved pancreatic beta cell function
• Improved glycemic control and immunomodulatory action

2. PLA General Hospital, China

• Phase-II randomized controlled trial used UC-MSCs for T2DM
• Improved level of HbA1c, pancreatic functional recovery
• Reduced insulin resistance, supports metabolic regulation

3. Vertex Pharmaceuticals, United States 

• Used VX-880 stem cell-derived islet cells for T1DM
• Significant reduction in insulin dependency

4. Stem Cell Therapy by Dr Sagar Jawale, India 

• Stem cell therapy for diabetes in India by Dr Jawale performed against T1DM and T2DM
• Used allogenic adipose-derived stem cells (ADSCs)
• In T1DM, regeneration of beta cells has been reported
• In T2DM, insulin dependency dropped significantly

Potential Benefits of Diabetes Stem Cell Treatment

• Improvement in blood sugar glucose regulation 
• Significant reduction in insulin dependency
• Improved energy level and daily functioning
• Improvement in metabolic health, improved quality of life of the individuals

What are the Key Considerations? 

The clinician conducts a detailed health assessment before recommending regenerative therapy.

• Consideration of medical history, co-morbid factors and current health condition 
• Use of superior quality stem cells for gaining the best outcome
• Consult a renowned clinic and experienced clinicians for the treatment

*Advancells, India, is a leading stem cell research laboratory that supplies superior quality stem cells for chronic diseases. The stem cells undergo a stringent quality check process and are maintained in a controlled laboratory environment. 

Can Stem Cell Therapy Combat Other Complications?

Beyond blood sugar management, researchers are constantly exploring stem cells for their ability to combat other complications. These conditions are generally not restored by medications. This includes:

• Neuropathy: Nerve ending regeneration and restores adequate blood flow
• Nephropathy: Reduces glomerular filtration rate (GFR), promotes podocyte repair
• Foot Ulcer: Improve wound healing
• Retinopathy: Restores retinal blood flow, improves retinal health
• Combat Inflammation: Reduces inflammation or associated pain

What is the Future of Stem Cells for Diabetes Research?

Currently, stem cell therapy for diabetes has displayed safety and tolerance among patients. It acts as supportive therapeutics and improves the efficacy of the conventional treatment. In future, the scope is multiple, including: 

• Development of a large-scale clinical trial for establishing long-term safety, efficacy, and tolerance among patients
• Development of personalized medicine and targeted regenerative medicine
• A combinational approach for a better outcome

Lifestyle Support Alongside Regenerative Approach

• Dietary intervention for better blood sugar management
• Regular physical activities
• Regular blood sugar monitoring & medication intake
• Management of stress, sleep patterns

Conclusion

Stem cells for diabetes have laid a new direction in diabetes management. Scientific innovation reflects potential in addressing the root cause of the problem rather than symptom regulation. Currently, stem cell therapy is at an early stage of development. In future advanced rigorous research is desirable for establishing it as a standard regenerative treatment.  

Diabetes Disease Patient Success Stories

References

1. World Health Organization. Diabetes [Internet]. Geneva: World Health Organization; 2024. Available from: WHO Diabetes Fact Sheet 
2. International Diabetes Federation. India. Brussels: International Diabetes Federation; 2024. Available from: International Diabetes Federation – India 
3. Li H, Chen C, Wang Y, Yi W, Guo P, Yao C, Liu J, Wei Y, Hu K, Shang X, Kang S. A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus. Stem cell research & therapy. 2025 May 19;16(1):249. 

FAQ’s

Q- Is Stem Cell Therapy for Diabetes Approved in India?

Currently, stem cell therapy is at an investigational stage. It is not approved as standard care for diabetes management. The registration occurs for clinical trials or acts as an adjunct regenerative therapy.

Q- Can Stem Cell Therapy Replace Insulin Completely?

No, currently, stem cell therapy for diabetes acts as supportive or adjunctive therapy. It is implied alongside the conventional treatment approaches. 

Q- Is Diabetes Stem Cell Treatment Safe?

Preclinical and clinical studies inferred the safety and tolerance of the stem cell therapy. In future, large-scale clinical trial outcomes are needed for establishing its long-term safety, efficacy, and tolerance.

Q- How Long Does it Take to See Results from Stem Cell Therapy for Diabetes?

Stem cell therapy outcomes vary among individuals. Typically, noticeable results appear between 3 and 6 months. Overall outcome depends on stem cell quality, source, isolation protocol, administration method, individual health factors, etc.